The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC
Post# of 316
(Total Views: 201)
Posted On: 07/19/2019 6:02:21 PM
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Shows Impressive Domestic, International Growth
- Supreme is building a diverse portfolio of domestic and global premium cannabis brands
- The company is revolutionizing strain development for the global cannabis market
- Supreme delivers consistently premium products and investment opportunities through its wholly owned subsidiaries and partnerships
Canada’s only coast-to-coast premium cannabis producer, The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is passionate about its products. The company provides high-quality brands and products that elevate its mission of becoming a leader in the global cannabis industry. Rather than focus on simply upping production, Supreme Cannabis pursues the production of the best cannabis possible, aiming for sustainable quality and superb craftsmanship. Consumers have come to expect the best from Supreme Cannabis brands, resulting in a loyal customer base for the company that continues to expand globally.
Supreme Cannabis has effectively built a diversified portfolio of successful cannabis brands. These brands include 7ACRES, Cambium Plant Sciences, Supreme Heights, KKE and Medigrow Lesotho. The company is expanding both domestically and internationally.
7ACRES operates from a 440,000-square-foot cultivation facility in Kincardine, Ontario. The facility’s annual capacity for dried cannabis is projected to reach approximately 50,000 kilograms per year following the licensing of all 25 flowering rooms. In May, 7ACRES obtained Health Canada approval for five additional flowering rooms, a move that means an increase from 180,000 square feet and an estimated annual capacity of 26,250 kilograms to 230,000 square feet and 33,580 kilograms.
“The finish line is in sight,” Supreme Cannabis president and founder John Fowler said in a news release. “As 7ACRES continues to work toward full production capacity, we are excited to fulfill demand for our high-end cannabis from enthusiasts coast to coast.”
The cannabis industry has taken notice of 7ACRES’ ability to cultivate high-end cannabis at scale, and a demand for the company’s proprietary genetics and cultivation techniques birthed the launch of Cambium Plant Sciences.
“It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market,” added Supreme Cannabis CEO Navdeep Dhaliwal. “Cambium will develop cultivars that benefit our in-house brands as well as our domestic and global cultivation and manufacturing partners.”
This wholly owned subsidiary aims to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the global cannabis industry (http://nnw.fm/V8gRD). Cambium will aim to provide disease-resistant, premium seed to the ever-increasing, agriculturally focused global cannabis market and establish itself as a leading player in revolutionizing strain development.
Supreme Heights is a separate entity based in London. This CBD-focused investment platform is tapping into the quickly developing premium-CBD health and wellness sector in the United Kingdom and across Europe. Supreme provides capital and guidance to help early-stage entrepreneurial firms. The company seeks to support businesses that embrace sustainability, innovation and community throughout the UK and Europe.
Khalifa Kush Enterprises (KKE) is an international partnership aimed at developing and launching a line of premium cannabis-oil products. The oils are created using 7ACRES’ high-end cannabis and are among the first-ever recreational-focused cannabis oils in Canada. KKE Oils are available in British Columbia, Alberta and Ontario, and are scheduled to be released to other Canadian provinces throughout the year.
Medigrow Lesotho is the company’s international medical cannabis oil producer in Southern Africa. South Africa’s Department of Health recently made changes that allowed for the legal sale of CBD products that meet the government’s specified preparations, creating more opportunity for Medigrow to manufacture and supply high-quality CBD oil to its neighboring jurisdiction. In anticipation of its first international exports, Medigrow is creating an inventory of oils.
Supreme’s business model also includes key industry agreements to facilitate an active growth plan, a continued commitment to identifying new opportunities to grow its portfolio on a global scale and additional partnerships with cannabis retailers to further distribution. The company is focused on growing both domestically and internationally.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Supreme is building a diverse portfolio of domestic and global premium cannabis brands
- The company is revolutionizing strain development for the global cannabis market
- Supreme delivers consistently premium products and investment opportunities through its wholly owned subsidiaries and partnerships
Canada’s only coast-to-coast premium cannabis producer, The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is passionate about its products. The company provides high-quality brands and products that elevate its mission of becoming a leader in the global cannabis industry. Rather than focus on simply upping production, Supreme Cannabis pursues the production of the best cannabis possible, aiming for sustainable quality and superb craftsmanship. Consumers have come to expect the best from Supreme Cannabis brands, resulting in a loyal customer base for the company that continues to expand globally.
Supreme Cannabis has effectively built a diversified portfolio of successful cannabis brands. These brands include 7ACRES, Cambium Plant Sciences, Supreme Heights, KKE and Medigrow Lesotho. The company is expanding both domestically and internationally.
7ACRES operates from a 440,000-square-foot cultivation facility in Kincardine, Ontario. The facility’s annual capacity for dried cannabis is projected to reach approximately 50,000 kilograms per year following the licensing of all 25 flowering rooms. In May, 7ACRES obtained Health Canada approval for five additional flowering rooms, a move that means an increase from 180,000 square feet and an estimated annual capacity of 26,250 kilograms to 230,000 square feet and 33,580 kilograms.
“The finish line is in sight,” Supreme Cannabis president and founder John Fowler said in a news release. “As 7ACRES continues to work toward full production capacity, we are excited to fulfill demand for our high-end cannabis from enthusiasts coast to coast.”
The cannabis industry has taken notice of 7ACRES’ ability to cultivate high-end cannabis at scale, and a demand for the company’s proprietary genetics and cultivation techniques birthed the launch of Cambium Plant Sciences.
“It was as a result of the demand that we saw a global opportunity to create a company whose sole focus is innovating plant genetics and cultivation IP for the global cannabis market,” added Supreme Cannabis CEO Navdeep Dhaliwal. “Cambium will develop cultivars that benefit our in-house brands as well as our domestic and global cultivation and manufacturing partners.”
This wholly owned subsidiary aims to lead the agricultural revolution of cannabis genetics, redefining consumer experiences and cultivation economics across the global cannabis industry (http://nnw.fm/V8gRD). Cambium will aim to provide disease-resistant, premium seed to the ever-increasing, agriculturally focused global cannabis market and establish itself as a leading player in revolutionizing strain development.
Supreme Heights is a separate entity based in London. This CBD-focused investment platform is tapping into the quickly developing premium-CBD health and wellness sector in the United Kingdom and across Europe. Supreme provides capital and guidance to help early-stage entrepreneurial firms. The company seeks to support businesses that embrace sustainability, innovation and community throughout the UK and Europe.
Khalifa Kush Enterprises (KKE) is an international partnership aimed at developing and launching a line of premium cannabis-oil products. The oils are created using 7ACRES’ high-end cannabis and are among the first-ever recreational-focused cannabis oils in Canada. KKE Oils are available in British Columbia, Alberta and Ontario, and are scheduled to be released to other Canadian provinces throughout the year.
Medigrow Lesotho is the company’s international medical cannabis oil producer in Southern Africa. South Africa’s Department of Health recently made changes that allowed for the legal sale of CBD products that meet the government’s specified preparations, creating more opportunity for Medigrow to manufacture and supply high-quality CBD oil to its neighboring jurisdiction. In anticipation of its first international exports, Medigrow is creating an inventory of oils.
Supreme’s business model also includes key industry agreements to facilitate an active growth plan, a continued commitment to identifying new opportunities to grow its portfolio on a global scale and additional partnerships with cannabis retailers to further distribution. The company is focused on growing both domestically and internationally.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Supreme Pharmaceuticals (SPRWF) Stock Research Links
Scroll down for more posts ▼